Literature DB >> 12598265

Continuous epidural infusion of large concentration/small volume versus small concentration/large volume of levobupivacaine for postoperative analgesia.

Mira Dernedde1, Michaela Stadler, Francoise Bardiau, Jean G Boogaerts.   

Abstract

UNLABELLED: In this randomized study, we evaluated the quality of postoperative analgesia and the incidence of side effects of continuous thoracic epidural levobupivacaine 15 mg/h in 2 different concentrations: 0.5%, 3 mL/h (n = 33) or 0.15%, 10 mL/h (n = 27). The following variables were registered within 48 h: sensory block, pain scores, rescue morphine consumption, motor blockade, hemodynamics, sedation, nausea and vomiting, and patient satisfaction. The two groups were similar with regard to demographics, cephalad level of sensory block, quality of analgesia, morphine consumption, side effects, and high satisfaction rate. Motor blockade was weaker in the 0.5% group (P = 0.025), with a significantly increased hemodynamic stability, compared with the 0.15% group (P = 0.004). In conclusion, the same dose of levobupivacaine provides an equal quality of analgesia in small- or large-volume continuous epidural infusion and decreases the incidence of motor blockade and hemodynamic repercussions. This is in accordance with the assumption that the total dose of local anesthetics determines the spread and quality of analgesia. IMPLICATIONS: We demonstrated that a large concentration/small volume of levobupivacaine given as a continuous thoracic epidural infusion provided an equal quality of postoperative analgesia as a small-concentration/large-volume infusion and induced less motor blockade and fewer hemodynamic repercussions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598265     DOI: 10.1213/01.ane.0000048977.66133.d5

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

Review 1.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

2.  A prospective, randomized, controlled trial of the postoperative analgesic effects of spraying 0.25 % levobupivacaine after bilateral axillo-breast approach robotic thyroidectomy.

Authors:  Jung-Hee Ryu; Cha Kyong Yom; Hyungju Kwon; Kyu Hyung Kim; June Young Choi; Jun Woo Jung; Sung-Won Kim; Ah-Young Oh
Journal:  Surg Endosc       Date:  2014-08-14       Impact factor: 4.584

3.  The postoperative analgesic effects of intra-articular levobupivacaine in elective day-case arthroscopy of the knee: a prospective, randomized, double-blind clinical study.

Authors:  Eva Jacobson; Hamid Assareh; Ronnie Cannerfelt; Russell E Anderson; Jan G Jakobsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-06-10       Impact factor: 4.342

4.  The effects of varying local anesthetic concentration and volume on continuous popliteal sciatic nerve blocks: a dual-center, randomized, controlled study.

Authors:  Brian M Ilfeld; Vanessa J Loland; J C Gerancher; Anupama N Wadhwa; Elizabeth M Renehan; Daniel I Sessler; Jonathan J Shuster; Douglas W Theriaque; Rosalita C Maldonado; Edward R Mariano
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

5.  Patient-controlled epidural levobupivacaine with or without fentanyl for post-cesarean section pain relief.

Authors:  Shin-Yan Chen; Feng-Lin Liu; Yih-Giun Cherng; Shou-Zen Fan; Barbara L Leighton; Hung-Chi Chang; Li-Kuei Chen
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

6.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

7.  The Analgesic Efficiency of Ultrasound-Guided Rectus Sheath Analgesia Compared with Low Thoracic Epidural Analgesia After Elective Abdominal Surgery with a Midline Incision: A Prospective Randomized Controlled Trial.

Authors:  Hany Mahmoud Yassin; Ahmed Tohamy Abd Elmoneim; Hatem El Moutaz
Journal:  Anesth Pain Med       Date:  2017-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.